Search Results 571-580 of 17099 for monoclonal antibody

  1. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects. Goldenberg DM. David M; Morschhauser ...

  2. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    ... monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27. View PubMed; Murphy BL, Glasgow AE, Keeney GL, Habermann ...

  3. Advancing a new era of regenerative medicine - Mayo Clinic News Network

    "Mayo Clinic has the clarity of vision to lead in this space. I'm grateful to be a part of it." ###. What's the latest on monoclonal antibody therapies to ...

  4. Mayo Clinic Q and A: Surgical and nonsurgical treatment options for vaginal prolapse

    Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 · 2021 Gerstner Awardees to investigate individualized ...

  5. Mayo Clinic Q & A - Dr. Gregory Poland - COVID- 19 Update Tra...

    The concern, the thing that keeps me up at night about this is that it will evade the monoclonal antibodies that we have to either prevent or treat SARS CoV-2.

  6. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

    Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell ...

  7. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

    To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...

  8. A First-in-Human Study of BG-C137, an Anti-FGFR2b Antibody Drug Conjugate, in Participants With Advanced Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor ...

  9. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Prior treatment with anti CD38 monoclonal antibodies. Treatment with ... History of Grade 4 anaphylactic reaction to monoclonal antibody therapy.

  10. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    Monoclonal antibodies ≤ 2 weeks;; Note: denosumab is exempt from this requirement and can be started at any time prior to initiation of palbociclib and ...